Latest ondansetron Stories
WARREN, N.J., July 11, 2011 /PRNewswire/ -- MonoSol Rx, a specialty pharmaceutical company and the developers of the PharmFilmÂ® technology platform, in collaboration with APR Applied Pharma Research s.a.
People seeking help for their alcohol or other drug problems enter treatment with very different levels of motivation to change.
WARREN, N.J., April 4, 2011 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilmÂ® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it has been granted U.S. patent No.
POINT RICHMOND, Calif., March 16, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.
POINT RICHMOND, Calif., March 14, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.
In research published this week in PLoS Medicine, Stephen Freedman (University of Toronto) and colleagues performed a cost analysis of the emergency department administration of oral ondansetron to children with dehydration and vomiting secondary to gastroenteritis and found that this treatment could provide substantial economic, as well as clinical, benefit.